get a key
steadybase-$ company ADMA
account_id none on file
legal_name Adma Biologics, Inc.
ticker ADMA
cik 1368514
domain admabiologics.com
entry_point_account_id none on file
name ADMA Biologics Inc
exchange Nasdaq
sector Health Care
hq Ramsey, NJ, United States
calls 3 filings 0 executives 3 family 0
why_nownone on file
calls
They love traveling. I've never seen a group of people that are more dedicated. But they're out there, and we're hitting all the right meetings. We're hitting all the regional meetings. We're hitting all the right outpatient infusion companies. And we're talking to docs. We're sponsoring medical education programs. we sponsor the clinical immunology society summer school i mean we're doing things that are really meaningful and i think are impacting and you know look it's it's again it's still a new product and we're still we still have a lot of room to grow as i've said a couple times today but what i'll say is that the awareness is there i believe that in in our small subset of clinical immunology uh physicians and infectious disease consults to the clinical immunology programs um This is not something that they haven't heard.

May 10, 2023 / receipt, needs a key / Adam, CEO | earnings call 2023-05-10 | transcript 597ab805-7a86-444f-9f97-78c083407bec | chars 45264-46103 | segment 46

The significant revenue growth coupled with our disciplined expense management established a strong foundation for the company to accelerate towards profitability.

Aug 10, 2022 / receipt, needs a key / Adam Grossman, CEO | earnings call 2022-08-10 | transcript c440f348-9662-49a8-927a-df1577b922c7 | chars 3396-3559 | segment 2

I mean, I was just traveling around a little bit now that the world is opening up at a couple of regional medical meetings and meeting with some of our KOLs.

Aug 10, 2022 / receipt, needs a key / Adam Grossman, other | earnings call 2022-08-10 | transcript c440f348-9662-49a8-927a-df1577b922c7 | chars 29271-29428 | segment 28

filingsnone on file
executives
Adam Grossman CEO - receipt
Brad Tade Chief Financial Officer and Treasurer linkedin receipt
Brian Lenz Executive Vice President and Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled webcast / ir
changes
2026-02-25 Chief Financial Officer, retiring sec_8k
2018-06-22 Executive Vice President and Chief Financial Officer, appointed sec_8k
2012-05-03 Vice President and Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$